Craig Millian

Craig Millian

Director Ejecutivo en HLS THERAPEUTICS INC. .

Fortuna: 50 660 $ al 31/07/2026

58 años
Health Technology
Consumer Services

Perfil

Craig Millian is currently Chief Executive Officer & Director at HLS Therapeutics, Inc. since 2023.
Former roles include Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc. from 2021 to 2023, Senior Vice President-Neurology & Immunology at EMD Serono, Inc. from 2016 to 2018, Vice President-Commercial at Vertex Pharmaceuticals, Inc., and a position at EMD Serono, Inc. from 2012 to 2018.
Education includes an undergraduate degree from the University of Pennsylvania and an MBA from New York University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
20/08/2026 17.000 ( 0,05 % ) 50 660 $ 31/07/2026

Cargos activos de Craig Millian

EmpresasCargoInicio
HLS THERAPEUTICS INC. Director Ejecutivo 01/05/2023

Antiguos cargos conocidos de Craig Millian.

EmpresasCargoFin
CORBUS PHARMACEUTICALS HOLDINGS, INC. Director de Operaciones 14/04/2023
Corporate Officer/Principal 01/12/2018
VERTEX PHARMACEUTICALS INCORPORATED Corporate Officer/Principal -
Ver el detalle de la experiencia de Craig Millian.

Formación de Craig Millian.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

68

Relaciones de 1er grado

6

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas6

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology